Systemic Inflammation Induced by Cardiopulmonary Bypass: A Review of Pathogenesis and Treatment

Journal of Extra-Corporeal Technology

Volumn 31, Issue 4, 1999, Pages 202-210

  Nieman, Gary ^a   Searles, Bruce ^b   Carney, David ^a   McCann, Ulysee ^a   Schiller, Henry ^a   Lutz, Charles ^a   Finck, Christine ^a   Gatto, Louis A ^c   Hodell, Michael ^a   Picone, Anthony ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Department of Cardiovascular Perfusion ^*  (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Acute respiratory distress syndrome (ARDS); Cardiopulmonary bypass; Endotoxin; Postpump syndrome; Systemic inflammatory response syndrome (SIRS); Two hit model

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; HUMAN; INFLAMMATION; LUNG FUNCTION; LUNG STRUCTURE; NEUTROPHIL; PATHOGENESIS;

EID: 0033510418     PISSN: None     EISSN: 29698960     Source Type: Journal    
DOI: 10.1051/ject/1999314202     Document Type: Conference Paper

References (58)

1. Fry DE. Multiple system organ failure. In: Fry DE, ed. Multiple System Organ Failure. St. Louis: Mosby-Year Book; 1992; 3–14.
2. Deitch EA. Multiple organ failure: Pathophysiology and potential future therapy. Ann Surg. 1992;216:117–134.
3. Starr NJ. In: Casthely PA, Bergman D, eds. Cardiopulmonary Bypass: Physiology, Related Complications, and Pharmacology. New York: Futura; 1991.
4. Messent M, Anaes FC, Registrar K, et al. Adult respiratory distress syndrome following cardiopulmonary bypass: Incidence and prediction. Anaesthesia 1992;47:267–268.
5. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med. 1987;13:89–95.
6. Kirklin JK. The post perfusion syndrome: Inflammation and the damaging effects of cardiopulmonary bypass. In: Tinker JH, ed. Cardiopulmonary Bypass: Current Concepts and Controversies. Philadelphia: Saunders; 1989: 131.
7. Butler J, Rocker G, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552–59.
8. Hirthler M, Simoni J, Dickson M. Elevated levels of endotoxin, oxygen-derived free radicals, and cytokines during extracorporeal membrane oxygenation. J Ped Surg. 1992;27:1199–1202.
9. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–55.
10. Fowler AA, Hamman RF, Good JT, et al. Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med. 1983;98:593–97.
11. Stephens KE, Ishizaka A, Larrick JW. TNF causes increased pulmonary permeability and edema. Am Rev Respir Dis. 1988;137:1364–70.
12. Kunkel SL, Remick DG, Strieter RM, et al. Mechanisms that regulate the production and effects of tumor necrosis factor alpha. Crit Rev Immunol. 1989;9:93–117.
13. Partrick DA, Moore FA, Moore EE, et al. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horiz. 1996;4:194–210.
14. Barnett CC, Moore EE, Moore FA, et al. Intercellular adhesion molecule-1 provokes polymorphonuclear leukocyte elastase release by CD18. Surgery. 1996;120:395–401.
15. Franciose R, Moore E, Moore F, et al. Hypoxia/ reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism. J Surg Res. 1996;61:459–62.
16. Biffl WL, Moore EE, Moore FA, et al. Interleukin-6 delays neutrophil apoptosis via a mechanism involving platelet-activating factor. J Trauma. 1996;40:575–78.
17. Koike K, Moore EE, Moore FA, et al. Gut phospholipase A2 mediates neutrophil priming and lung injury after mesenteric ischemia-reperfusion. Am J Physiol. 1995;268: G397–G403.
18. Koike K, Moore EE, Moore FA, et al. Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res. 1992;52:656–62.
19. Taggart DP, Sundaram S, McCartney C, et al. Endotoxemia, complement, and white blood cell activation in cardiac surgery: A randomized trial of laxatives and pulsatile perfusion. Ann Thorac Surg. 1994;57:376–82.
20. Edmunds LH, Ellison N, Coleman RW. Platelet function during open heart surgery: Comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg. 1982;83: 805–12.
21. Malech HL, Gallin JI. Neutrophils in human diseases. N Engl J Med. 1987;317:687–94.
22. Weiss SJ. Destruction by neutrophils. N Engl J Med. 1989; 320:365–76.
23. Dakin HD, Cohen JB, Kenyon J. Studies in antiseptics (II): On chloramine: Its preparation, properties, and use. Br Med J. 1916;1:852–54.
24. Klebanoff SJ. Phagocytic cells: Products of oxygen metabolism. In: Gallin JI, Goldstein IM, Snyderman R., eds. Inflammation: Basic Principles and Clinical Correlates. New York: Raven Press; 1988: 391–444.
25. Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome: Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest. 1983;71:754–61.
26. Kondoh Y, Taniguchi H, Taki F, et al. 7S collagen in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest. 1992;101:1091–1094.
27. Kawamura MF, Yamasawa F, Ishizaka R, et al. Serum concentration of 7S collagen and prognosis in patients with the adult respiratory distress syndrome. Thorax. 1994;49:144–46.
28. Carney D, Lutz C, Picone A, et al. Matrix metalloproteinase inhibitor prevents acute lung injury following cardiopulmonary bypass. Circulation. 1999;100:400–406.
29. Woessner JF. The family of matrix metalloproteinases. Ann NY Acad Sci. 1994;732:11–21.
30. d’Ortho MP, Jarreau PH, Delacourt C, et al. Matrix metalloproteinase and elastase activities in endotoxin-induced acute lung injury in guinea pigs. Am J Physiol. 1994;266: L209–L216.
31. Delcaux C, d’Ortho M-P, Delacourt C, et al. Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am J Physiol. 1997;272:L442–L451.
32. Torri K, Iida K-I, Miyazaki Y, et al. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:43–6.
33. Ricou B, Nicod L, Lacraz S, et al. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:346–52.
34. Lee DT, Fein AM, Lipmann M, et al. Elastase activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med. 1981;304:192–96.
35. Anderson BO, Brown JM, Bensard DD, et al. Reversible lung neutrophil accumulation can cause lung injury by elastase-mediated mechanisms. Surgery. 1990;108:262–68.
36. Ferry G, Lonchampt M, Pennel L, et al. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. Fed Eur Biochem Societies. 1997;402:111–15.
37. Donnelly SC, MacGregor I, Zamani A, et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995; 151:1428–33.
38. 2 metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. J Appl Physiol. 1986;61: 2224–229.
39. 4-induced lung injury in rabbit. J Appl Physiol. 1994;76: 91–6.
40. Peterson MW, Walter ME, Nygaard SD. Effect of neutrophil mediators on epithelial permeability. Am J Respir Cell Mol Bio. 1995;13:719–27.
41. Lee H-M LM, Golub D, Chan M, et al. Alpha-1-proteinase inhibitor in gingival crevicular fluid of humans with adult periodontitis: Serpinolytic inhibition by doxycycline. J Periodont Res. 1997;32:9–19.
42. Milano S, Arcoleo F, D’Agostino P, et al. Intraperitoneal injection of tetracyclines protects mice form lethal endotoxemia down-regulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob Agents Chemother. 1997;41:117–121.
43. Uchiba M, Okajima K, Murakami K, et al. Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats. Am J Respir Crit Care Med. 1997;155:711–18.
44. O’Donovan DA, Kelly CJ, Bouchier-Hayes DM, et al. Alpha-1 antichymotrypsin is an effective inhibitor of pancreatitis-induced lung injury. Eur J Gastroenterol Hepatol. 1995;7:847–52.
45. Okumura Y, Inoue H, Fujiyama Y, et al. Effects of serine protease inhibitors on accumulation of polymorphonuclear leukocytes in the lung induced by acute pancreatitis in rats. J Gastroenterol. 1995;30:379–86.
46. Sakamaki F, Ishizaka A, Urano T, et al. Effect of a specific neutrophil elastase inhibitor ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med. 1996;153:391–97.
47. Kubo K, Kobayashi T, Hayano T, et al. Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep. J Appl Physiol. 1994;77: 1333–40.
48. Miyazaki Y, Inoue T, Sawads M, et al. Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNFa) and activated neutrophils in isolated perfused rabbit lungs. Am J Respir Crit Care Med. 1998;157:89–94.
49. Gossage JR, Kuratomi Y, Davidson JM, et al. Neutrophil elastase inhibitors, SC-37698 and SC-39026, reduce endotoxin-induced lung dysfunction in awake sheep. Am Rev Respir Dis. 1993;147:1371–79.
50. Ashraf S, Tian Y, Cowan D, et al. Release of proinflammatory cytokines during pediatric cardipulmonary bypass: Heparin-bonded versus nonbonded oxygenators. Ann Thorac Surg. 1997;64:1790–94.
51. Picone AL, Lutz C, Finck C, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg. 1999;67:978–85.
52. Van der Poll T, Buller HR, Cate HT, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med. 1990;322:1622–86.
53. Gamble JR, Harlan JM, Klebonoff SJ, et al. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA. 1985;82:8667–71.
54. Larrick JW, Graham D, Toy K, et al. Recombinant tumor necrosis factor causes activation of human granulocytes. Blood. 1987;69:640–44.
55. Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 1986; 320:584–88.
56. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit Care Med. 1997;25:1095–1100.
57. Carney D, Lutz C, Picone A, et al. Soluble tumor necrosis factor receptor (TNFbp) prevents post-pump syndrome. J Surg Res.1999;83:113–21.
58. Van der Poll T, Coule, SM, Levi M, et al. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood. 1997;89:3727–34.